StonvexLoading…
StonvexCore line items from AXSM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $638.50M | $385.69M | $270.60M | $50.04M |
Operating Income | $-166.76M | $-280.56M | $-231.82M | $-179.80M |
Net Income | $-183.17M | $-287.22M | $-239.24M | $-187.13M |
EPS (Diluted) | $-3.68 | $-5.99 | $-5.27 | $-4.60 |
Total Assets | $689.80M | $568.50M | $588.24M | $331.48M |
Total Liabilities | $601.51M | $511.48M | $397.26M | $221.92M |
Cash & Equivalents | $322.93M | $315.35M | $386.19M | $200.84M |
Free Cash Flow OCF − CapEx | $-93.89M | $-128.68M | $-145.66M | $-117.21M |
Shares Outstanding | 50.88M | 48.67M | 47.35M | 43.50M |